US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 1.9000
  • -0.0750-3.80%
Close Jan 17 16:00 ET
  • 1.9800
  • +0.0800+4.21%
Post 20:01 ET
33.35MMarket Cap-3.80P/E (TTM)

Lexaria Bioscience Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
Total revenue
21.58%183.92K
105.24%464.28K
173.25%84K
8.10%84K
624.09%145K
54.78%151.28K
-11.43%226.21K
-72.34%30.74K
-22.07%77.71K
-34.67%20.03K
Operating revenue
22.31%183.92K
142.65%463.38K
100.64%84K
8.10%84K
624.09%145K
62.51%150.38K
13.67%190.97K
4.04%41.87K
-22.07%77.71K
-34.67%20.03K
Cost of revenue
-43.59%2.72K
-84.69%4.82K
0
0
0
-69.47%4.82K
-56.15%31.5K
0
-31.60%12.75K
-53.69%2.96K
Gross profit
23.73%181.2K
135.97%459.46K
173.25%84K
29.31%84K
749.59%145K
78.74%146.46K
6.08%194.71K
-56.02%30.74K
-19.88%64.96K
-29.66%17.07K
Operating expense
123.39%2.87M
-7.67%6.21M
99.77%2.29M
-25.91%1.83M
-39.36%813.01K
-27.67%1.29M
-1.09%6.73M
39.88%1.14M
-1.34%2.47M
-8.98%1.34M
Selling and administrative expenses
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
-11.99%567.23K
-24.98%711.11K
-38.26%3.06M
39.41%644.45K
-52.77%825.18K
-46.17%644.51K
-General and administrative expense
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
-11.99%567.23K
-24.98%711.11K
-38.26%3.06M
39.41%644.45K
-52.77%825.18K
-46.17%644.51K
Research and development costs
239.99%1.95M
-35.62%2.36M
93.28%967.21K
-65.07%573.09K
-64.70%245.78K
-30.74%574.49K
98.99%3.67M
40.49%500.41K
118.14%1.64M
152.53%696.18K
Operating profit
-136.20%-2.69M
11.95%-5.75M
-97.74%-2.2M
27.40%-1.74M
49.53%-668.01K
32.81%-1.14M
1.28%-6.53M
-48.84%-1.11M
0.72%-2.4M
8.63%-1.32M
Net non-operating interest income expense
-99.85%11
-66.87%14.31K
-22.44%6.99K
0
-100.01%-1
95.64%7.32K
43.19K
9.02K
15.44K
14.99K
Non-operating interest income
-99.85%11
-66.87%14.31K
-22.44%6.99K
--0
----
95.64%7.32K
--43.19K
--9.02K
--15.44K
--14.99K
Non-operating interest expense
----
----
----
----
--1
----
----
----
----
----
Other net income (expense)
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
862.51%15.27K
31.45%-53.22K
71.01%-221.69K
-143.92K
1.86K
-2K
Gain on sale of security
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
862.51%15.27K
31.45%-53.22K
71.01%-221.69K
---143.92K
--1.86K
---2K
Income before tax
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
33.02%-1.19M
9.09%-6.71M
17.46%-1.25M
1.44%-2.38M
9.53%-1.31M
Income tax
Net income
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
33.02%-1.19M
9.09%-6.71M
17.46%-1.25M
1.44%-2.38M
9.53%-1.31M
Net income continuous Operations
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
33.02%-1.19M
9.09%-6.71M
17.46%-1.25M
1.44%-2.38M
9.53%-1.31M
Minority interest income
48.75%-2.93K
72.06%-13.31K
81.63%-1.78K
78.29%-2.62K
74.46%-3.19K
57.23%-5.72K
58.34%-47.63K
78.78%-9.7K
65.94%-12.06K
45.38%-12.51K
Net income attributable to the parent company
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
49.96%-649.54K
32.84%-1.18M
8.31%-6.66M
15.55%-1.24M
0.48%-2.37M
8.95%-1.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
49.96%-649.54K
32.84%-1.18M
8.31%-6.66M
15.55%-1.24M
0.48%-2.37M
8.95%-1.3M
Basic earnings per share
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
72.73%-0.06
56.67%-0.13
18.55%-1.01
50.00%-0.12
9.76%-0.37
12.00%-0.22
Diluted earnings per share
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
72.73%-0.06
56.67%-0.13
18.55%-1.01
50.00%-0.12
9.76%-0.37
12.00%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023
Total revenue 21.58%183.92K105.24%464.28K173.25%84K8.10%84K624.09%145K54.78%151.28K-11.43%226.21K-72.34%30.74K-22.07%77.71K-34.67%20.03K
Operating revenue 22.31%183.92K142.65%463.38K100.64%84K8.10%84K624.09%145K62.51%150.38K13.67%190.97K4.04%41.87K-22.07%77.71K-34.67%20.03K
Cost of revenue -43.59%2.72K-84.69%4.82K000-69.47%4.82K-56.15%31.5K0-31.60%12.75K-53.69%2.96K
Gross profit 23.73%181.2K135.97%459.46K173.25%84K29.31%84K749.59%145K78.74%146.46K6.08%194.71K-56.02%30.74K-19.88%64.96K-29.66%17.07K
Operating expense 123.39%2.87M-7.67%6.21M99.77%2.29M-25.91%1.83M-39.36%813.01K-27.67%1.29M-1.09%6.73M39.88%1.14M-1.34%2.47M-8.98%1.34M
Selling and administrative expenses 29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M-11.99%567.23K-24.98%711.11K-38.26%3.06M39.41%644.45K-52.77%825.18K-46.17%644.51K
-General and administrative expense 29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M-11.99%567.23K-24.98%711.11K-38.26%3.06M39.41%644.45K-52.77%825.18K-46.17%644.51K
Research and development costs 239.99%1.95M-35.62%2.36M93.28%967.21K-65.07%573.09K-64.70%245.78K-30.74%574.49K98.99%3.67M40.49%500.41K118.14%1.64M152.53%696.18K
Operating profit -136.20%-2.69M11.95%-5.75M-97.74%-2.2M27.40%-1.74M49.53%-668.01K32.81%-1.14M1.28%-6.53M-48.84%-1.11M0.72%-2.4M8.63%-1.32M
Net non-operating interest income expense -99.85%11-66.87%14.31K-22.44%6.99K0-100.01%-195.64%7.32K43.19K9.02K15.44K14.99K
Non-operating interest income -99.85%11-66.87%14.31K-22.44%6.99K--0----95.64%7.32K--43.19K--9.02K--15.44K--14.99K
Non-operating interest expense ------------------1--------------------
Other net income (expense) 70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K862.51%15.27K31.45%-53.22K71.01%-221.69K-143.92K1.86K-2K
Gain on sale of security 70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K862.51%15.27K31.45%-53.22K71.01%-221.69K---143.92K--1.86K---2K
Income before tax -128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K33.02%-1.19M9.09%-6.71M17.46%-1.25M1.44%-2.38M9.53%-1.31M
Income tax
Net income -128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K33.02%-1.19M9.09%-6.71M17.46%-1.25M1.44%-2.38M9.53%-1.31M
Net income continuous Operations -128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K33.02%-1.19M9.09%-6.71M17.46%-1.25M1.44%-2.38M9.53%-1.31M
Minority interest income 48.75%-2.93K72.06%-13.31K81.63%-1.78K78.29%-2.62K74.46%-3.19K57.23%-5.72K58.34%-47.63K78.78%-9.7K65.94%-12.06K45.38%-12.51K
Net income attributable to the parent company -129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M49.96%-649.54K32.84%-1.18M8.31%-6.66M15.55%-1.24M0.48%-2.37M8.95%-1.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M49.96%-649.54K32.84%-1.18M8.31%-6.66M15.55%-1.24M0.48%-2.37M8.95%-1.3M
Basic earnings per share -23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.1372.73%-0.0656.67%-0.1318.55%-1.0150.00%-0.129.76%-0.3712.00%-0.22
Diluted earnings per share -23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.1372.73%-0.0656.67%-0.1318.55%-1.0150.00%-0.129.76%-0.3712.00%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Heat List
US
Overall
Symbol
Price
% Chg

No Data